They say this vaccine, tested in humans, elicits the creation of broadly neutralising antibodies (bnAbs), which can recognise the globally diverse strains of HIV, and could protect against infection. They say this trial induced bnAb-precursor responses in 26 of the 27 vaccine recipients (97%).
This is a companion discussion topic for the original entry at https://www.sciencemediacentre.co.nz/2022/12/02/trial-results-for-potential-hiv-vaccine-show-promise-expert-reaction/?utm_source=rss&utm_medium=rss&utm_campaign=trial-results-for-potential-hiv-vaccine-show-promise-expert-reaction